BOSTON PARIS BIOTECHNOLOGY SUMMIT™
Boston Biotechnology Summit 2022: a Virtual [Sept.] and In-Person [Oct.] program covering Medical Research and Business Issues Facing Biotechnology Companies Worldwide.
[Cambridge MA, USA, Released 19 SEPT 2022] The Boston Paris Biotechnology Summit™ 2022 will be held in two parts; virtually [29 Sept.] and in-person [14 Oct.] at CIC, the Cambridge Innovation Center, Cambridge 02142, USA.
This comprehensive program features nationally and internationally reputed speakers covering Medical Research and Business Issues Facing Biotechnology Companies: Talent Acquisition and Retention, US Legal and Regulatory Strategy, Funding & Management in Times of Crisis, a virtual Special Lecture on Monkeypox, Clinical Development and Trials – State-of-the-Art, and an in-person Master Class on Commercial strategy.
FACULTY LISTED ALPHABETICALLY
Yvette CLELAND, CEO CPL Life Sciences, London, UK. – Nominated as one of the top 50 most powerful women in staffing worldwide.
Marc DE GARIDEL, CEO Cincor Pharma, Boston MA, USA. Previously served as CEO of Corvidia Therapeutics, a private Boston-based clinical-stage company acquired by Novo Nordisk in 2020 for $2.1 Billion.
Marc B. GARNICK, M.D., Gorman Brothers Professor of Medicine at Harvard Medical School & the Beth Israel Deaconess Medical Center Boston MA, USA.
Vanessa EL HARRAR, MD, MPH, Vice President, Vaccines Business Strategy Lead at PPD [Thermo Fisher Scientific], Wilmington, NC, USA.
Naji Gehchan, MD, Global Development Leader Oncology at Eli Lilly & Co, Cambridge MA, USA.
Daniel KURITZKES, Harriet Ryan Albee Professor of Medicine at Harvard Medical School and Chief of the Division of Infectious Diseases at Brigham and Women’s Hospital, Boston, MA, USA.
Cecile LE CAMUS, MD, MBA, Global Head of Hemophilia for Rare Blood Diseases, Medical Affairs Group, Sanofi-Genzyme, Cambridge MA, USA.
Corinne LE GOFF, PharmD, MBA, CEO Celsion, NJ, USA (& Cambridge MA). Corinne Le Goff’s was listed by Forbes magazine in 2021 as “One of 100 Women Changing the World”.
Anup MADAN, PhD, Director of Biomarkers for PPD® Laboratories, part of Thermo Fisher Scientific, Seattle, WA, USA.
Brian MALKIN, JD (Law), Partner, IP and FDA Practice McDermott Will & Emery,
Washington DC, USA.
Regis MULOT, EVP and Chief HR Officer, IPSEN, Paris, France.
Delphine SARAGOUSSI MD, MScPH, Executive Director, Real-World Evidence, Strategic & Scientific Affairs at EVIDERA (PPD, part of Thermo Fisher Scientific) Greater Paris Region, France.
Ann M. STOWE, PhD, Associate Professor with Tenure, Dept. of Neurology at the University of Kentucky (Lexington, KY, USA) & Co-founder CERELUX LLC.
PROGRAM COMMITTEE: 6th Boston Biotechnology Summit 2022 PROGRAM COORDINATION COMMITTEE
Vanessa EL HARRAR, MD, MPH
Vice-President, Vaccines Strategy Lead, PPD Biotech [Thermo Fisher Group], FL, USA. Formerly, Office of the Director, NIH: National Institutes of Health, MD, USA.
Jessica FOLEY, MS, RAC
[Regulatory Affairs Certified]
Principal & Founder,
Gaia Regulatory Sciences,
Cambridge MA, USA.
Silvia HELOU, MD,
Principal & Executive Medical Consultant, Helou Consulting, LLC
New York Metropolitan Area, USA.
Professor Frederic JALLAT,
Academic Director – Biopharmaceutical Management,
ESCP Business School, Paris, France. Campus Sites: Berlin, London, Madrid, Paris, Turin & Warsaw.
Brian MALKIN, JD,
Partner, IP and FDA PRACTICE,
McDermott, Will & Emery,
International Law Firm,
Washington DC, USA
Karine ROSSIGNOL, PharmD
CEO, SMART IMMUNE. Co-General Secretary, INSTITUT IMAGINE, for Rare Genetic Diseases, Paris, France.
2022 SPONSORS:
[Major/Founding Sponsors]
PPD BIOTECH [Thermo Fisher Scientific Group], USA
MCDERMOTT, WILL & EMERY LLP, USA.
CPL Life Sciences, UK.
[2022 Sponsors]
ACTIVE Biomarkers, France
BANOOK Group, France.
[Friends of the Summit]
B2G Life Sciences, France
About the Boston Biotechnology Summit
An exclusive, Trans-Atlantic bridge designed to foster innovative synergies between biotech and pharma companies, healthcare-focused cities, regional clusters and institutional, philanthropic and strategic investors.
The Summit’s intent is to spark projects, their financing and strategic deals to solve unmet medical needs to improve patient lives globally.
www.bostonbiotechnologysummit.com
All Inquiries
Soheila Gharakhanian, Summit Co-Founder & President, Blend of Concept LLC <blendofconcept@gmail.com>, Summit Producer.